However, no significant difference was observed in the plasma levels of THRIL, LincRNA-Cox2, LincRNA-p21, HULC, SLC26A4-AS1 and APOA1-AS between patients with CAD and controls (Fig. 1C–H). This evidence concerns the gene APOA1 and coronary artery disorder.